Gilead in China
To transform and simplify care for people with life-threatening diseases – this has been Gilead’s commitment since the company launched operations in China in 2017. Gilead has introduced nine innovative medicines in China for chronic HBV, HCV and HIV prevention & treatment. Seven of those medicines have been included in the National Reimbursement Drug List (NRDL), making it possible for more people to access the innovative medicine and come back to healthy life.
Today, we have over 600 employees in more than 80 cities in China.
Click here to read the Gilead China narrative brochure.
Scan the QR code to follow our social media.